slotkoers
INDONESIA S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2.320
IDR
|
0,00%
|
|
-0,43%
|
-10,42%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
5.688.144
|
5.552.712
|
5.715.230
|
7.313.328
|
7.448.760
|
7.015.378
|
Bedrijfswaarde
1 |
4.261.178
|
4.375.026
|
3.949.573
|
5.758.312
|
6.579.735
|
6.469.271
|
K/w-verhouding
|
8,71
x
|
9,56
x
|
8,4
x
|
8,63
x
|
8,79
x
|
10,2
x
|
Dividendrendement
|
4,29%
|
4,39%
|
9,48%
|
7,59%
|
7,45%
|
-
|
Marktkapitalisatie/omzet
|
0,28
x
|
0,25
x
|
0,25
x
|
0,28
x
|
0,27
x
|
0,25
x
|
Bedrijfswaarde/omzet
|
0,21
x
|
0,2
x
|
0,18
x
|
0,22
x
|
0,23
x
|
0,23
x
|
Bedrijfswaarde/EBITDA
|
4,43
x
|
5
x
|
4,36
x
|
4,86
x
|
5,26
x
|
6,16
x
|
Bedrijfswaarde/FCF
|
10,9
x
|
-38,9
x
|
5,86
x
|
38,3
x
|
-30,3
x
|
40,4
x
|
FCF Yield
|
9,2%
|
-2,57%
|
17,1%
|
2,61%
|
-3,3%
|
2,47%
|
Price to Book
|
0,98
x
|
0,91
x
|
0,87
x
|
1,07
x
|
1,05
x
|
0,97
x
|
Aantal aandelen (in duizenden)
|
2.708.640
|
2.708.640
|
2.708.640
|
2.708.640
|
2.708.640
|
2.708.640
|
Referentieprijs
2 |
2.100
|
2.050
|
2.110
|
2.700
|
2.750
|
2.590
|
Datum van publicatie
|
29/03/19
|
3/04/20
|
29/03/21
|
31/03/22
|
28/03/23
|
28/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
20.604.487
|
22.226.912
|
22.545.419
|
25.673.757
|
28.027.488
|
28.507.873
|
EBITDA
1 |
962.103
|
875.467
|
904.943
|
1.185.835
|
1.251.054
|
1.050.294
|
Bedrijfsresultaat (EBIT)
1 |
834.841
|
747.361
|
767.386
|
1.034.226
|
1.094.573
|
894.749
|
Operationele Marge
|
4,05%
|
3,36%
|
3,4%
|
4,03%
|
3,91%
|
3,14%
|
Resultaat voor belastingen (EBT)
1 |
879.481
|
813.103
|
882.740
|
1.091.263
|
1.101.140
|
892.425
|
Nettowinst (verlies)
1 |
653.064
|
580.630
|
680.598
|
847.881
|
847.533
|
688.499
|
Nettomarge
|
3,17%
|
2,61%
|
3,02%
|
3,3%
|
3,02%
|
2,42%
|
WPA
2 |
241,1
|
214,4
|
251,3
|
313,0
|
312,9
|
254,2
|
Free Cash Flow
1 |
392.045
|
-112.331
|
673.874
|
150.176
|
-217.420
|
159.991
|
FCF-marge
|
1,9%
|
-0,51%
|
2,99%
|
0,58%
|
-0,78%
|
0,56%
|
Kasstroomconversie (ebitda)
|
40,75%
|
-
|
74,47%
|
12,66%
|
-
|
15,23%
|
Kasstroomconversie (nettowinst)
|
60,03%
|
-
|
99,01%
|
17,71%
|
-
|
23,24%
|
Dividend per aandeel
2 |
90,00
|
90,00
|
200,0
|
205,0
|
205,0
|
-
|
Datum van publicatie
|
29/03/19
|
3/04/20
|
29/03/21
|
31/03/22
|
28/03/23
|
28/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
1.426.966
|
1.177.686
|
1.765.657
|
1.555.016
|
869.025
|
546.107
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
392.045
|
-112.331
|
673.874
|
150.176
|
-217.420
|
159.991
|
ROE (netto-inkomsten/eigen vermogen)
|
12%
|
9,75%
|
10,7%
|
12,6%
|
12,1%
|
9,54%
|
ROA (netto-inkomsten/totale activa)
|
6,63%
|
5,49%
|
5,35%
|
6,83%
|
6,8%
|
5,24%
|
Totale activa
1 |
9.855.787
|
10.583.462
|
12.712.427
|
12.423.167
|
12.470.870
|
13.148.068
|
Nettoactief per aandeel
2 |
2.136
|
2.262
|
2.415
|
2.522
|
2.626
|
2.676
|
Cashflow per aandeel
2 |
466,0
|
384,0
|
598,0
|
489,0
|
365,0
|
253,0
|
Capex
1 |
121.349
|
307.742
|
201.029
|
107.175
|
111.985
|
169.561
|
Capex/omzet
|
0,59%
|
1,38%
|
0,89%
|
0,42%
|
0,4%
|
0,59%
|
Datum van publicatie
|
29/03/19
|
3/04/20
|
29/03/21
|
31/03/22
|
28/03/23
|
28/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -10,42% | 387 mln. | | +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|